In non-colorectal gastrointestinal cancers, including hepatocellular carcinoma, pancreatic cancer, and gastric cancers, high expression of SIRT1 was clearly associated with worse OS, and there was no evidence of statistical heterogeneity or bias. This evidence concerns the gene SIRT1 and gastric cancer.